Home | News | Brisbane biotech company booming in US

Brisbane biotech company booming in US

The partnership between a Brisbane biotechnology company formed by The University of Queensland's Institute for Molecular Bioscience (IMB) and a publicly traded pharmaceutical company based on the east coast of the United States is expanding.

Please login below to view content or subscribe now.

Membership Login

Get the news delivered straight to your inbox

Receive the top stories in our weekly newsletter Sign up now

To continue onto Campus Review, please select your institution.